Doximity, Inc. financials

  1. Home
  2. Financials
  3. DOCS
DOCS CIK 0001516513

Source: EDGAR filings · Built 2026-06-02T02:50:48Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2022
Free Cash Flow 326.46M 273.26M 183.95M 177.90M 124.66M 82.73M
EBITDA 229.30M 238.46M 174.14M 135.39M 118.58M 57.01M
Working Capital 789.29M 932.36M 765.69M 835.95M 792.86M 107.36M
Net Debt -208.99M -197.22M -82.24M -142.39M -111.72M -65.14M
Gross Margin 89.09% 90.20% 89.34% 87.24% 88.42% 84.92%
Operating Margin 33.33% 39.94% 34.47% 29.86% 33.05% 25.76%
Net Margin 30.40% 39.13% 31.04% 26.92% 45.05% 24.27%
Return on Equity (ROE) 20.62% 20.62% 16.37% 11.68% 17.62% 75.23%
Return on Assets (ROA) 17.45% 17.65% 13.67% 9.92% 15.61% 19.95%
Current Ratio 6.09× 6.97× 6.20× 6.99× 8.12× 2.05×
Debt-to-Equity 0.01× 0.01× 0.02× 0.02× 0.00× 0.02×
Effective Tax Rate 21.58% 15.32% 20.31% 15.27% -35.77% 13.08%
Cash Conversion Ratio 1.67× 1.22× 1.25× 1.59× 0.82× 1.65×
Accruals Ratio -0.12× -0.04× -0.03× -0.06× 0.03× -0.13×
SBC % of Revenue 18.86% 12.69% 10.74% 11.41% 9.15% 3.51%
CapEx Coverage — — 1252.35× 105.59× 66.20× 338.67×
Free Cash Flow Per Share $1.64 $1.36 $0.89 $0.83 $0.65 $0.87

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2022
P/E Trailing (Diluted) 23.78× 52.28× 37.38× 61.09× 74.41× —
P/FCF 14.21× 42.73× 30.10× 38.84× 79.82× —
FCF Yield 7.04% 2.34% 3.32% 2.57% 1.25% —
EV / EBITDA 17.69× 45.14× 28.36× 45.33× 83.58× —
P/S 6.61× 19.22× 10.56× 14.99× 29.17× —
P/B 4.49× 10.12× 5.57× 6.50× 11.41× —

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2022
Revenue from Contract with Customer, Excluding Assessed Tax 644.86M 570.40M 475.42M 419.05M 343.55M 206.90M
Cost of Revenue 70.33M 55.87M 50.67M 53.49M 39.79M 31.20M
Gross Profit 574.54M 514.52M 424.75M 365.56M 303.76M 175.70M
Research and Development Expense 130.70M 93.04M 81.98M 80.19M 62.35M 43.87M
Operating Expenses 359.62M 286.73M 260.88M 240.45M 190.22M 122.40M
Operating Income (Loss) 214.92M 227.80M 163.88M 125.11M 113.54M 53.30M
Income Tax Expense (Benefit) 53.95M 40.39M 37.62M 20.34M -40.78M 7.56M
Net Income (Loss) Attributable to Parent 196.05M 223.19M 147.58M 112.82M 154.78M 50.21M
Earnings Per Share, Basic $1.05 $1.19 $0.78 $0.58 $0.82 $0.29
Weighted Average Number of Shares Outstanding, Basic 187.01M 186.84M 190.17M 193.18M 163.48M 74.34M
Earnings Per Share, Diluted $0.98 $1.11 $0.72 $0.53 $0.70 $0.23
Weighted Average Number of Shares Outstanding, Diluted 199.05M 201.21M 205.73M 213.43M 191.02M 95.13M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2022
Cash and Cash Equivalents, at Carrying Value 219.18M 209.61M 96.78M 158.03M 112.81M 66.39M
Assets, Current 944.26M 1.09B 912.94M 975.45M 904.14M 209.40M
Assets 1.12B 1.26B 1.08B 1.14B 991.36M 251.72M
Liabilities, Current 154.97M 156.26M 147.25M 139.51M 111.28M 102.04M
Liabilities 172.85M 181.68M 177.98M 170.77M 112.76M 103.52M
Stockholders' Equity Attributable to Parent 950.84M 1.08B 901.40M 966.12M 878.59M 66.74M
Common Stock, Shares, Outstanding 183.06M 188.88M 186.56M 193.94M 192.40M 82.91M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2022
Net Cash Provided by (Used in) Operating Activities 326.46M 273.26M 184.10M 179.60M 126.58M 82.97M
Payments to Acquire Property, Plant, and Equipment 0 0 147.00K 1.70M 1.91M 245.00K
Net Cash Provided by (Used in) Investing Activities 147.17M -29.30M 31.19M -59.92M -640.57M -70.42M
Payments for Repurchase of Common Stock 431.65M 120.29M 280.72M 85.32M 2.70M 2.02M
Net Cash Provided by (Used in) Financing Activities -464.06M -131.14M -276.52M -74.46M 560.41M 5.41M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DOCS CIK 0001516513), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

UPB

UPSTREAM BIO, INC.

CZR

CAESARS ENTERTAINMENT, INC.

MRAM

Everspin Technologies, Inc.